Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is SACUBITRIL VALSARTAN SODIUM, with a corresponding US DMF Number 35480.
Remarkably, this DMF maintains an Active status since its submission on December 28, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 15, 2025, and payment made on December 13, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II